A detailed history of Cowen And Company, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 6,288 shares of CTLT stock, worth $399,162. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,288
Holding current value
$399,162
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.16 - $60.96 $353,134 - $383,316
6,288 New
6,288 $380,000
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $218,599 - $341,675
3,021 New
3,021 $219,000
Q2 2022

Aug 05, 2022

SELL
$87.2 - $114.05 $270,407 - $353,669
-3,101 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $95,602 - $126,357
1,015 Added 48.66%
3,101 $344,000
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $249,423 - $290,100
2,086 New
2,086 $267,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.